NRD
SILK

Nebula Research & Development’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Nebula Research & Development’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,517
Closed -$541K – 1090
2024
Q1 		$541K Sell
29,517
-41,073
-58% -$652K 0.12% 328
2023
Q4 		$866K Buy
70,590
+58,447
+481% +$548K 0.26% 96
2023
Q3 		$182K Buy
+12,143
New +$253K 0.1% 413
2023
Q2 		– Sell
-5,132
Closed -$201K – 472
2023
Q1 		$201K Buy
+5,132
New +$251K 0.35% 177

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Nebula Research & Development's SILK Position: Q2 2024 in Review

Nebula Research & Development sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 29,517 shares — an estimated $541K sold.

Nebula Research & Development first reported a position in SILK in Q1 2023 and held it in 4 quarters. The position peaked at $866K in Q4 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Nebula Research & Development reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Nebula Research & Development sold 29,517 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $541K.
  • Nebula Research & Development first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Nebula Research & Development's Silk Road Medical, Inc. Common Stock position peaked at $866K in Q4 2023.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Nebula Research & Development's 13F filing for Q2 2024, filed 14 Aug 2024.